Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
October 18 2018 - 5:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION
OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS
13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission
File Number
000-53071
TARGETED
MEDICAL PHARMA, INC.
(Exact name of registrant as specified in
its charter)
2980 BEVERLY GLEN CIRCLE, SUITE 100
LOS ANGELES, CA 90077
(310) 474-9808
(Address, including zip code, and telephone
number, including area code, of registrant’s principal executive offices)
Common Stock
(Title of each class of securities covered
by this Form)
None
(Titles of all other classes of securities
for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate
rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)
|
x
|
|
|
|
|
Rule 12g-4(a)(2)
|
¨
|
|
|
|
|
Rule 12h-3(b)(1)(i)
|
¨
|
|
|
|
|
Rule 12h-3(b)(1)(ii)
|
¨
|
|
|
|
|
Rule 15d-6
|
¨
|
Approximate number of holders of record as of the certification
or notice date:
289
Pursuant to the requirements of the Securities Exchange Act
of 1934, Targeted Medical Pharma, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly
authorized person.
Date:
|
October 18, 2018
|
|
By:
|
/s/ Marcus Charuvastra
|
|
|
|
|
Marcus Charuvastra
Interim Chief Executive Officer
|
Targeted Medical Pharma (CE) (USOTC:TRGM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Targeted Medical Pharma (CE) (USOTC:TRGM)
Historical Stock Chart
From Sep 2023 to Sep 2024